UK pushes continuous manufacturing

The University of Strathclyde aims to give drug manufacturing the greatest of gifts: continuous processing. It hopes to escort the pharma industry out of the batch era through a UK initiative to revive high-tech manufacturing industries.

Two of nine centers for innovative manufacturing--which will apply "inventive research and business acumen" to big manufacturing problems, according to Universities and Science Minister David Willetts in a statement--target biopharmaceuticals. "Partnerships between higher education and industry are drivers of innovation, opportunity and national prosperity."

GlaxoSmithKline is the industry partner to the University of Strathclyde in the continuous manufacturing effort. The pair will tackle such challenges as offshore outsourcing and cutbacks to lower fixed costs. The objective is making pharma manufacturing again a sustainable UK industry.

- see the University of Strathclyde release
- here's the story
- get more

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.